AUTHOR=Jin Xin Hang , Li Yang , Li Dan TITLE=Intrauterine interventions for women with two or more implantation failures: A systematic review and network meta-analysis JOURNAL=Frontiers in Endocrinology VOLUME=13 YEAR=2022 URL=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.959121 DOI=10.3389/fendo.2022.959121 ISSN=1664-2392 ABSTRACT=Objective

To compare the effectiveness of different intrauterine interventions for women with two or more unexplained implantation failures.

Design

A systematic review and network meta-analysis of randomized controlled trials (RCTs).

Patient(s)

Women with two or more implantation failures undergoing fresh or frozen embryo transfer (ET).

Intervention(s)

An electronic search of the following databases: Pubmed, Cochrane Central Register of Controlled Trials (CENTRAL), and Embase.

Main Outcome Measure(s)

Clinical pregnancy, live birth/ongoing pregnancy, and miscarriage.

Result(s)

We included 21 RCTs(3079 women) in the network meta-analysis. The network meta-analysis showed that compared with control treatment, platelet-rich plasma(PRP), peripheral blood mononuclear cells (PBMC), granulocyte colony-stimulating factor(G-CSF), human chorionic gonadotropin(HCG), and endometrial scratch(ES) significantly increased clinical pregnancy(OR 3.78, 95% CI 2.72 to 5.25; 2.79, 95% CI 1.75 to 4.45; 1.93, 95% CI 1.37 to 2.72; 1.80, 95% CI 1.18 to 2.72; 1.75, 95% CI 1.29 to 2.36, respectively). PRP ranked the highest in improving clinical pregnancy, followed by PBMC, G-CSF, HCG, and ES. Compared with control treatment, PRP, PBMC, and ES significantly increased live birth/ongoing pregnancy (OR 5.96, 95% CI 3.38 to 10.52; OR 2.55, 95% CI 1.27 to 5.11; OR 1.70, 95% CI 1.07 to 2.69, respectively). PRP ranked the highest in improving live birth/ongoing pregnancy, followed by PBMC, and ES.

Conclusion(s)

PRP is the most effective intrauterine intervention in improving pregnancy outcome in women with two or more implantation failures.